Medication Tapering/Withdrawal

Sometimes I get so sick of the lies of biological psychiatry that I must speak out. At these moments I find silence to be a kind of emotional death: a death of my spirit, a death of my critical faculties, a death of my courage. I speak out because I am alive and I wish to align with life.

A new study to be published in the next issue of Schizophrenia Research examines patients suffering from a first-episode of psychosis who stop taking any antipsychotic drugs. The researchers attempt to identify variables that can serve as predictors of the successful discontinuation of antipsychotics. They find, for example, that those who discontinue the drugs have, on average, the same outcomes as those who stay on them, and that those who have better social integration are more likely to discontinue without relapse.

World Benzodiazepine Awareness Day has just launched its official website, w-bad.org. The new site includes useful information about benzodiazepines, ideas for taking action, and video...

A new study explores how people manage to discontinue antipsychotic medication and examines how social supports may improve outcomes.

From Pacific Standard: A new study surveyed people who have come off psychiatric medications to come up with information doctors can use to help support their...

Many people now using psychiatric drugs have been convinced or forced to use them while being treated in the mental health system. A good number of people are eager to stop using these drugs, but are often discouraged by others from doing so. Many psychiatric survivors believe that they can never stop using these drugs because they were told they would need to use them the rest of their lives. We hope the Sunrise Center will become a catalyst for a movement of people creating places for people who want to stop using psychiatric drugs.

The American Psychological Association (APA) recently published a study finding that patients assigned to drug-only treatments were more likely to refuse treatment, and more likely to drop out before treatment completion, than patients assigned to psychotherapy only.

An analysis of medical records in the UK reveals that the use of certain antidepressants for depression is linked to a heightened risk for mania and bipolar disorder. The research, published this week in BMJ Open, found the strongest effect for serotonin reuptake inhibitors (SSRIs) and the antidepressant venlafaxine.

The ocean’s waves are constant and unchangeable, bound by earth and gravity; for a long time I believed life was this way, too—that who I was and how I felt and what I believed about myself were all bound by some invisible force that would always keep me trapped in a perpetual state of agonizing being. What a beautiful thing to know that after so many years of believing this, I’ve proven myself wrong.

I was a psychiatrist who participated in the Recovery After an Initial Schizophrenia Episode Early Treatment Program (RAISE ETP). Although I welcomed the positive headlines that heralded the study's results, the reports left me with mixed feelings. What happened to render the notion that talking to people about their experiences and helping them find jobs or go back to school is something novel?

In this video from Business Insider, psychopharmacologist and psychiatrist Dr. Samoon Ahmad explains the impact of Xanax on the brain and discusses some of...

The May issue of Addiction includes a review of pharmacological and phenomenological issues around benzodiazepine (BZD) and SSRI discontinuation.  Definitions, perceptions and management of the...

For a long time I have felt that there just isn’t a good enough and long enough study on the pros and cons of long-term antipsychotic treatment versus reduction and discontinuation in people who have psychotic disorders, including those who are classified as having schizophrenia. Moreover, there are increasing reasons to be worried about the effects of long-term treatment with antipsychotics. I put this case to the UK’s National Institute of Health Research recently, and proposed that they fund a trial to assess the long-term outcomes of a gradual programme of antipsychotic reduction compared with standard ‘maintenance treatment.’ The NIHR agreed that this was an important issue, and that a new trial was urgently needed. The RADAR (Research into Antipsychotic Discontinuation And Reduction) study officially started in January 2016.

From The Washington Post: Despite major lawsuits and detailed reports pertaining to severe health risks associated with the antipsychotic Seroquel, the drug remains one of...

My name is Leah Harris and I'm a survivor. I am a survivor of psychiatric abuse and trauma. My parents died largely as a result of terrible psychiatric practice. Psychiatric practice that took them when they were young adults and struggling with experiences they didn’t understand. Experiences that were labeled as schizophrenia. Bipolar disorder. My parents were turned from people into permanent patients. They suffered the indignities of forced treatment. Seclusion and restraint. Forced electroshock. Involuntary outpatient commitment. And a shocking amount of disabling heavy-duty psychiatric drugs. And they died young, from a combination of the toxic effects of overmedication, and broken spirits.

When language has been ingrained in a culture for a long time, it takes a concerted effort to change it. How do we stop using the word “addiction” in relation to cases of iatrogenic benzo dependence? Here are a few suggestions.

Researchers from the City College of New York and Columbia University published a study this month testing the hypothesis that people diagnosed with schizophrenia treated long-term with antipsychotic drugs have worse outcomes than patients with no exposure to these drugs. They concluded that there is not a sufficient evidence base for the standard practice of long-term use of antipsychotic medications.

In 2014, then National Institute of Mental Health (NIMH) director, Thomas Insel, speculated that ketamine “might be the most important breakthrough in antidepressant treatment in decades.” A recent review of the research suggests that while ketamine may produce a rapid short-term improvement in depression, the effect is short-lived and the potential for addiction and dependence warrants considerable caution.

The Harm Reduction Guide to Coming Off Psychiatric Drugs, written by Will Hall and published by The Icarus Project and Freedom Center five years...

From New Scientist: Some organizations are helping people hack their dosing regimens so they can taper off psychiatric drugs without severe withdrawal effects. One Dutch organization...

Psychiatric medications such as antipsychotics and antidepressants account for a huge number of published research studies. This existing research, however, is almost exclusively constrained within a medical model approach, purporting to evaluate medications as treatment for biological brain disorders, and designing studies accordingly. The disease, and how medications presumably affect it, is at the center — with pharmaceutical company financial interests not far behind. That paradigm is starting to change.

Members of the group Benzodiazepine Recovery have created a video about the often debilitating symptoms of benzodiazepine withdrawal. Video →­

It's been five years today since I completed a six year withdrawal process from a large cocktail of psychiatric drugs. Today is also my 50th birthday which, frankly, seems much more remarkable to me at this point. Inside I am only aware of eternal youth. Upon having done an informal and small survey, it seems most people feel that way though it's not talked about much among the adults of our species. That which watches and experiences our lives in these bodies does not age. It's actually a wonderful thing. So I'm here wondering what comes next in this amazing trajectory which is the life being lived in this body that my parents called Monica.

In this piece for Medium, Michael E. Lee tells his story of experiencing the horrific withdrawal effects of Effexor, and how he healed from his...

From The New York Times: Global prescription rates and long-term use of antidepressants are rising rapidly. One unanticipated consequence of this trend is that more...